Ipca Labs share price hits new high; Motilal Oswal upgrades stock to 'buy'
In the past one week, the stock of the pharmaceutical company has rallied 14 per cent as compared to 0.16 per cent decline in ...
Stock Radar: Pharma stocks in focus! Laurus Labs looking attractive after 10% fall from 52-week high
Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity ...
The Phnom Penh Post54m
Pathbreaking HIV drug’s generic version to be made in India
Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...
Analyst Call Tracker: Divi's Labs wins back favour after Nifty 50 departure
While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...
ndtvprofit20h
Indian Pharma Market Posts Moderate Revenue Growth In September
In the period between January and September, the Indian pharmaceutical market grew by an average of 7.6%, but volume growth ...
Daily22h
Rs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by Sun Pharma disallowed: IT Tribunal
Ahmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore ...